antiparkinson drugs (3) Flashcards

1
Q

parkinson’s disease is a progressive condition based on decreased ______ in the brain

A

dopamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is one of the main drugs used to replace dopamine

A

carbidopa-levodopa

(rapid swings in response to the medication can occur: on-off phenomenon)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

describe the OFF (too little) swing in response to levodopa

A
  • wearing-off phenomenon
  • medication may lose effectiveness towards the end of each dose
  • complementary drugs or an increased dose may be needed
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

____: difficulty with voluntary movements can occur during the ON (too much) phenomenon

A

dyskinesia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

selegiline and rasagiline are examples what what type of drug

A

indirect-acting dopaminergic drugs: monoamine oxidase inhibitors (MAOIs)

  • increase dopaminergic stimulation in the CNS

(these drugs are MAO-B inhibitors)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

with doses higher than 10mg of MAOIs there is a “cheese effect”, what is this effect

A

ingesting tyramine (cheese, beer, red wine, some yogurts) can cause severe hypertension, headache, and “feeling ill”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

dopamine modulators like amantadine increase amounts of available dopamine to decrease ______

A

dyskinesia

(only effective for 6-12 months)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

catechol ortho-methyltransferase (COMT) inhibitors are taken to do what

(tolcapone, entacapone, opicapone)

A

limit “off” episodes; prolong duration of action of levodopa and reduce the wearing-off phenomenon

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

name an adverse effect of COMT inhibitors

A

liver failure

(urine discoloration is expected, take with food, can worsen dyskinesias)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

name the two types of direct-acting dopamine receptor agonists

A
  • nondopamine receptor agonists (NDDRAs)
  • dopamine replacement drugs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

name side/adverse effects of nondopamine receptor agonists (NDDRAs)

A

GI upset, dyskinesias, sleep disturbances

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

name a dopamine replacement drug

A

carbidopa-levodopa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is levodopa converted into when it crosses the blood-brain barrier

A

dopamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

large doses of levodopa have systemic, ______ effects

A

cardiovascular

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

_______ is given with levodopa to prevent levodopa breakdown in blood vessels

A

carbidopa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

name some adverse effects of carbidopa-levodopa therapy (sinemet)

A

confusion, involuntary movements, cardiac dysrhythmias

17
Q

name the effects of anticholinergics

A

dry mouth or decreased salivation, urinary retention, decreased GI motility (constipation), dilated pupils (mydriasis)

-opposite effects of acetylcholine

(treat muscle tremors, rigidity associated with PD from excess Ach)

18
Q

what are some ways to manage the symptoms of anticholinergics

A

chew gum, drink frequently, use candy, eye drops

19
Q

why should one be cautious during hot weather or exercise while taking the anticholinergic benztropine

A

it may cause hyperthermia (decreased sweating)

20
Q

what should one avoid while taking the anticholinergic benztropine

A

alcohol

21
Q

name some adverse effects of the anticholinergic benztropine

A

confusion, disorientation, toxic psychosis

22
Q

what should patients be taught not to do while taking antiparkinson drugs

A

discontinue them suddenly

23
Q

what are some things that can be monitored for when reviewing response to drug therapy

A

increased ability to perform ADLs, concentrate, and think clearly